Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Complex issues relating to ethics, values, and
the nature of evidence lie behind the decision whether to give the MMR
(mumps, measles, and rubella) vaccine. Tom Heller, a general
practitioner, is uncomfortable with the evidence that the vaccine is
safe. Together with Dick Heller, an epidemiologist, and Stephen
Pattison, an ethicist, he explores some of the processes involved in
doctors' decisions about whether to vaccinate.
Tom Heller School of Health and Social Welfare
at the Open University, Milton Keynes, MK7 6AA
t.d.heller{at}open.ac.uk
My duties as a general practitioner include immunising
babies and small children against a range of common diseases. Recently, I have been increasingly uncomfortable when giving the combined mumps,
measles, and rubella (MMR) vaccine. I find myself wondering if I would
submit my own children for this immunisation if they were currently at
that age.
I find it difficult to be certain that the vaccine is as safe as the
authorities say that it is. Somehow, the more strident the experts
become, the less believable I seem to find them. The Department of
Health website (http://193.32.28.83/mmrvac.htm) gives many references
and internet links to the published studies that support its views, but
it gives only one reference that raises the issue of a link between MMR
vaccine and potential adverse reactions.
The partial use of evidence that is apparent within official
pronouncements is echoed by other experts. For example, Elliman and
Bedford focus on possible problems with the research methods of people
concerned about possible adverse effects of the MMR vaccine.1 They do not mention potential problems with the
research that concludes that the vaccines are safe. In addition, what
are we to make of these and other researchers2 who declare
funding from drug manufacturers involved in manufacturing vaccines?
Listening to people and parents
The NHS Plan emphasises the need to give people in receipt
of treatment and services a greater part in the decisions that affect
them and the NHS in general.3 However, for some reason, the choices seem restricted when it comes to discussing MMR vaccine. But parents remain anxious. Those with autistic children have become
sensitised to the possibility that the condition may have been caused
by an intervention such as vaccination.4
Other parents are convinced of the link between the MMR vaccine and
their child's subsequent development of autism and have formed support
groups and lobbying organisations. In the United Kingdom the main
organisation is JABS (Justice, Awareness, and Basic Support,
www.jabs.org.uk). When does a series of individual observations from
families with affected children count as evidence if each one is
dismissed as an isolated incident?
Professional issues
In the United Kingdom, general practitioners receive a fee
for each child immunised and other payments are triggered for meeting targets. Missing these targets would have serious consequences for the
financial stability of the practice, and there is considerable pressure on members of the team to ensure that children are immunised with every recommended vaccine.
I am not alone in my concern, and possible confusion, about
administering the MMR vaccine. A recent survey of health workers in
north Wales sought to elicit the knowledge, attitudes, and practices
relating to MMR vaccine, particularly the second dose.5 Only 45% of the professionals (54% of the general practitioners) agreed completely with the policy of giving the second dose of the MMR
vaccine. These professional concerns do not seem to have greatly
affected the numbers of children receiving the vaccine, and national
MMR coverage has only fallen from 91% in 1994-5 to 88% in 1998-9, although in some districts the uptake is below 75%.6
It is not easy to question authority these days.7 Andrew
Wakefield, the author of some of the studies that have
questioned the development and subsequent use of MMR vaccine, has been
subjected to personal as well as professional abuse
(www.autism-spectrum.com/vaccine.htm). Perhaps keeping my head down and
not even talking about these issues would be the easiest option.
Footnotes
Competing interests: None declared.
References
Dick Heller Evidence for Population Health
Unit, School of Epidemiology and Health Sciences, Medical School,
University of Manchester, Manchester M13 9PT
Dick.Heller{at}man.ac.uk
The basic question is, "what is the real evidence about
the dangers of MMR vaccine?" The evidence for a link between MMR
vaccine and the development of autism is based on a hypothesis derived from an observation that the parents of eight out of 12 children investigated for gastrointestinal symptoms and autism associated the
onset of autism with the MMR vaccine.1 There has been no evidence to support the hypothesis.
Several studies have been reported as negating the hypothesis, although
there are doubts about each of these. Some of the studies are
ecological in design; they examine trends in the development of autism
with the trends in use of MMR vaccine. Recently reported studies
2 3
show that the rise in reported autism over the past decade or so bears no relation to any changes in rates of MMR
vaccination, and this is consistent with other data showing no
epidemiological evidence for a causal association.
4 5
Most people who have reviewed the evidence have rejected the notion that MMR might be associated with autism.6-8 A recent
review from the US Institute of Medicine concludes that "the evidence favours rejection of a causal relationship."9
Listening to people and parents
Unfortunately, patients are often not
precise at identifying the cause of their illness, and personal
anecdote can do no more than suggest a hypothesis that needs formal
scientific testing: "Hypotheses can become `facts' long before the
critical data are in."10 The concern in the community
comes from the difficulty in understanding and expressing evidence. All
we have at the moment is a hypothesis based on anecdote, without
supporting evidence. Any evidence that does exist, however weak it
might be perceived to be, fails to support the hypothesis.
Comparing risk of autism with risk of vaccine preventable
diseases
It is difficult to measure, express, and
understand risk. The prevalence of autistic spectrum disorders is
91/100 000 children.11 If as many as 15% of these
children had autism as a result of the MMR vaccine, 7326 children would
have to be vaccinated to "produce" one child with autism. How many
cases of mumps, measles, or rubella would the lack of vaccination of
this number of children produce? What would their complication rates
be? Unfortunately, we have not established good intelligence systems to
explore the public health effects of changes in
immunisation.12 We do know that for measles alone, death
rates are 1-2 per 1000 infected people in the United States and that 1 in 1000 will get encephalitis (and some of these will have permanent
brain damage).13 If most children who were not vaccinated
developed measles, the complication rates suggest that discontinuing
vaccination would do considerable harm and that this harm would far
outweigh any possible benefit from possibly reducing the incidence of autism.
These common communicable diseases cannot be eliminated if the levels
of immunisation in the community fall below a critical value. It is a
legitimate concern of those with responsibility for public health to
seek to maintain high vaccination rates.
In summary, I feel that there is no evidence that MMR vaccine causes
autism and considerable evidence to say that it does not. I believe
that the dangers of reducing vaccination on the basis of an
unsubstantiated hypothesis are considerable.
Footnotes
Competing interests: None declared.
References
Stephen Pattison Department of Religious and
Theological Studies, Cardiff University, Cardiff CF10
3EU
Pattisons{at}cardiff.ac.uk
Some moral theorists would say that Tom
Heller is just having an emotional reaction, but I would say that this
kind of discomfort is part of moral judgment.1 He applies
one of the best known tests for assaying the rightness or wrongness of
acts called the golden rule,2 expressing this as, "would
I submit my own children for this immunisation if they were currently
at that age?" He also discusses the voice of authority that says it
is safe to administer MMR vaccine and how his doubts are amplified in
inverse proportion to the experts' certainty. The question is, then,
how might his colleagues and members of the public be helped to live with reality and limits of knowledge without necessarily abandoning useful public health practices that may be in their long term interests?
Although the scientists may be deemed to be working on one paradigm of
rationality and correlative enlightenment, ordinary people, including
doctors, have a more complex view of reality. This kind of composite
knowledge is often seen, from a rational point of view, as superstition
and irrationality which needs to be dispelled and destroyed.
You cannot discount another's knowledge even if you may doubt its
scientific value. Making a decision to have a child immunised is a
moral dilemma for parents and this must be respected. Not acknowledging
others' moral dilemmas does not make them go away. There is a crisis
of expert authority and trust in scientific judgment surrounding MMR
vaccine and a crisis of mutual respect. A decision needs to be
made about what kind of evidence counts and how this is weighed and
related to lay views of reality. In doing so, scientists must take care
not to treat fear and reservation as ignorance and then try to destroy
it with a blunt "rational" instrument.
I wonder if people know that general practitioners are given financial
incentives to deliver a certain proportion of vaccinations. This again
raises the issue of whether doctors are acting in the best interests of
the individuals or whether they are dancing to a financial tune. We
need to ask whose interests do and should clinicians serve Risk and power are unequally distributed in this situation. The
government determines the risk management strategy to deal with
the diseases mumps, measles, and rubella. However, it is individual
clinicians and parents who have to implement this strategy and may have
to live with its consequences. The MMR vaccine issue focuses many of
our concerns about ethical and responsive public health in the clinical
context in a helpful way. We are trying to work out what individually
respectful and sensitive, publicly accountable, evidence based clinical
practice might look like.
Footnotes
Competing interests: None declared.
References
Tom Heller I feel as though I have been through a
process which is rather similar to the explorations that many parents
go through at the time of taking important vaccine related decisions on
behalf of their children. My search for understanding will have to
continue. Of course, I respect that the full weight of the most
powerful authority figures in modern medicine have concluded that MMR
vaccine is safe (box), but lingering doubts remain for me and for many others.
Committee on Safety of Medicines Committee on Safety of Medicines and Medicines Control Agency
Joint Committee on Vaccination and Immunisation Working group of the Medical Research Council Public Health Laboratory Service Communicable Disease
Surveillance Centre Royal College of Paediatrics and Child Health World Health Organization My final thoughts are summed up in the following quotation:
"Informed refusal must remain an acceptable choice in a free
democracy, and the culture of informed consent, with both religious and
philosophical exemption, must be maintained. The difficult balancing
act will be in determining the right of the state to control an
infectious disease and the right of the individual to
chose."2
References

Whether to vaccinate children can be a difficult decision
1.
Elliman D, Bedford H.
MMR vaccine: the continuing saga.
BMJ
2001;
322:
183-184 2.
Kaye J, Melero-Montes M, Jick H.
Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis.
BMJ
2001;
322:
460-463 3.
Department of Health.
The NHS Plan.
London: Stationery Office, 2000. (CM 4818-I.)
4.
Goldberg D.
MMR, autism, and Adam.
BMJ
2000;
320:
389 5.
Petrovic M, Roberts R, Ramsay M.
Second dose of measles, mumps and rubella vaccine: questionnaire survey of health professionals.
BMJ
2001;
322:
82-85 6.
Public Health Laboratory Service facts and figures.
www.phls.co.uk/facts/vaccination/cover.htm (accessed 18 Sep 2001).
7.
Hunt G, ed.
Whistleblowing in the health service.
London: Edward Arnold, 1995.
Validity of the evidence
1.
Wakefield A, Murch S, Anthony A, Linnell J, Casson D, Malik M, et al.
Ileal-lymphoid nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children.
Lancet
1998;
351:
1327-1328[CrossRef][Medline].
2.
Kaye J, Melero-Montes M, Jick H.
Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis.
BMJ
2001;
322:
460-463.
3.
Dales L, Hammer SJ, Smith NJ.
Time trends in autism and in MMR immunisation coverage in California.
JAMA
2001;
285:
1183-1185 4.
Taylor B, Miller E, Farrington C, Petropoulos M-C, Favot-Mayaud I, Li J, et al.
Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association.
Lancet
1999;
353:
2026-2029[CrossRef][Medline].
5.
Patja A, Davidkin I, Kurki T, Kallio MJ, Valle M, Peltola H.
Serious adverse events after measles-mumps-rubella vaccination during a fourteen year prospective follow-up.
Pediatr Infect Dis J
2000;
19:
1127-1134[Medline].
6.
Nicoll A, Elliman D, Ross E.
MMR vaccination and autism.
BMJ
1998;
316:
715-716 7.
Wise J.
Finnish study confirms safety of MMR vaccine.
BMJ
2001;
322:
130 8.
Roberts R.
MMR vaccination and autism.
BMJ
1998;
316:
1824 9.
Institute of Medicine. Immunisation safety review:
measles-mumps-rubella vaccine and autism.
http://books.nap.edu/books/0309074479/html/index.html (accessed 5 Sep
2001).
10.
Gellin BG, Schaffner W.
The risk of vaccination
the importance of "negative" studies.
N Engl J Med
2001;
344:
372-37311.
Roberts R.
MMR vaccination and autism.
BMJ
1998;
316:
1824.
12.
Heller RC, Page J. A population perspective to evidence based
medicine
"evidence for population health." J Epidemiol
Community Health (in press).
13.
Watson JC, Hadler SC, Dykewicz CA, Reef S, Phillips L.
Measles, mumps, and rubella
vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP).
MMWR Morb Mortal Wkly Rep
1998;
47(RR-8):
1-57[Medline].
Dealing with uncertainty
do they
focus on individuals, or is their job to deliver centrally determined,
scientifically informed, health policy?
1.
Oakley J.
Morality and the emotions.
London: Routledge, 1992.
2.
Singer P, ed.
A companion to ethics.
Oxford: Blackwell, 1991.
GP's response
Groups that have endorsed safety record of MMR
vaccine1
1.
Committee on Safety of Medicines.
MMR vaccine: the facts.
Current Problems in Pharmacovigilance
2001;
27:
3.
2.
Poland G, Jacobson R.
Vaccine safety: injecting a dose of common sense.
Mayo Clinic Proceedings
2000;
75:
135-139[Medline].
© BMJ 2001
Read all Rapid Responses